The undesirable cardiotoxicity caused by CDK9 treatment requires extra vigilance, as the death of patients receiving targeted therapy is not limited to tumor occurrence and metastasis but fatal cardiovascular complications such as severe heart failure and malignant arrhythmia (35). Here, CDK9 is linked to neoplasm.